Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.

× No keyword cloud information.

12 in total

Review 1. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Authors: N Misaghian; G Ligresti; L S Steelman; F E Bertrand; J Bäsecke; M Libra; F Nicoletti; F Stivala; M Milella; A Tafuri; M Cervello; A M Martelli; J A McCubrey
Journal: Leukemia Date: 2008-09-18 Impact factor: 11.528

Review 2. Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review.

Authors: Ljiljana Serman; Tamara Nikuseva Martic; Alan Serman; Semir Vranic
Journal: Bosn J Basic Med Sci Date: 2014-11-12 Impact factor: 3.363

3. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

Authors: Yaxiong Tang; Anne R Simoneau; Wu-xiang Liao; Guo Yi; Christopher Hope; Feng Liu; Shunqiang Li; Jun Xie; Randall F Holcombe; Frances A Jurnak; Dan Mercola; Bang H Hoang; Xiaolin Zi
Journal: Mol Cancer Ther Date: 2009-01-27 Impact factor: 6.261

4. Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/β-catenin signaling pathway in Jurkat cells.

Authors: Yan Wang; Zunsong Wang; Hong Li; Wenwei Xu; Lin Dong; Yan Guo; Saran Feng; Kehong Bi; Chuansheng Zhu
Journal: Exp Ther Med Date: 2017-03-06 Impact factor: 2.447

5. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.

Authors: Ji Tae Kim; Jing Li; Eun Ryoung Jang; Pat Gulhati; Piotr G Rychahou; Dana L Napier; Chi Wang; Heidi L Weiss; Eun Y Lee; Lowell Anthony; Courtney M Townsend; Chunming Liu; B Mark Evers
Journal: Carcinogenesis Date: 2013-01-25 Impact factor: 4.944

6. Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients.

Authors: Chor Sang Chim
Journal: J Transl Med Date: 2010-11-26 Impact factor: 5.531

7. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia.

Authors: H-A Hou; Y-Y Kuo; C-Y Liu; M C Lee; J-L Tang; C-Y Chen; W-C Chou; C-F Huang; F-Y Lee; M-C Liu; M Yao; H-F Tien
Journal: Br J Cancer Date: 2011-11-17 Impact factor: 7.640

Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.